PEAK6 Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$792K Buy
+7,200
New +$750K ﹤0.01% 2170
2018
Q1
Sell
-4,900
Closed -$483K 4440
2017
Q4
$483K Sell
4,900
-4,000
-45% -$379K ﹤0.01% 2503
2017
Q3
$833K Sell
8,900
-60,200
-87% -$6.39M ﹤0.01% 2121
2017
Q2
$7.68M Buy
69,100
+41,100
+147% +$4.35M 0.04% 488
2017
Q1
$2.75M Sell
28,000
-96,800
-78% -$9.23M 0.02% 898
2016
Q4
$11.5M Buy
124,800
+31,600
+34% +$2.72M 0.08% 307
2016
Q3
$7.89M Sell
93,200
-18,300
-16% -$1.54M 0.06% 458
2016
Q2
$9.08M Sell
111,500
-142,800
-56% -$10.9M 0.07% 374
2016
Q1
$18.2M Buy
254,300
+141,000
+124% +$9.46M 0.15% 144
2015
Q4
$8.06M Buy
113,300
+32,400
+40% +$2.18M 0.05% 465
2015
Q3
$4.97M Buy
80,900
+64,800
+402% +$4.53M 0.03% 895
2015
Q2
$1.17M Buy
16,100
+2,100
+15% +$155K 0.01% 1934
2015
Q1
$1.08M Sell
14,000
-1,000
-7% -$71.6K 0.01% 1807
2014
Q4
$1.01M Buy
15,000
+2,000
+15% +$126K 0.01% 1949
2014
Q3
$789K Buy
13,000
+6,400
+97% +$394K 0.01% 2045
2014
Q2
$387K Sell
6,600
-14,300
-68% -$837K ﹤0.01% 2563
2014
Q1
$1.21M Buy
20,900
+6,100
+41% +$327K 0.01% 1683
2013
Q4
$792K Sell
14,800
-206,600
-93% -$12.3M 0.01% 2259
2013
Q3
$6.85M Buy
221,400
+164,400
+288% +$9.84M 0.05% 546
2013
Q2
$3.46K Buy
+57,000
New +$3.4M 0.01% 1059

Other funds holding DGX

PEAK6 Group's DGX Position: Q1 2018 in Review

PEAK6 Group sold out of Quest Diagnostics (DGX) in Q1 2018, closing a stake of 12,392 shares — an estimated $1.22M sold.

PEAK6 Group first reported a position in DGX in Q2 2013 and held it in 9 quarters. The position peaked at $1.22M in Q4 2017. 652 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

  • PEAK6 Group reported no remaining Quest Diagnostics position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 12,392 Quest Diagnostics shares in Q1 2018, an estimated $1.22M.
  • PEAK6 Group first reported a position in Quest Diagnostics in Q2 2013 and held it in 9 quarters.
  • PEAK6 Group's Quest Diagnostics position peaked at $1.22M in Q4 2017.
  • 652 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.